Structural Studies of SUMO Protein Modification

SUMO蛋白修饰的结构研究

基本信息

  • 批准号:
    8266481
  • 负责人:
  • 金额:
    $ 39.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-07-01 至 2014-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Signal transduction pathways rely on reversible chemical modifications to relay information within and across cells. Covalent modification of protein substrates by the ubiquitin-like protein SUMO (small ubiquitin-like modifier) contributes to pathways that regulate core cellular functions including nuclear transport, cytokinesis, chromosome segregation, G2-M cell cycle progression and transcriptional regulation among many others. Post-translational modification by ubiquitin (Ub) and ubiquitin-like (Ubl) proteins such as SUMO requires the sequential action of E1 activating enzymes, E2 conjugating enzymes and E3 ligases while Ub/Ubl processing and deconjugation is catalyzed by Ub/Ubl-specific proteases. Because SUMO conjugation plays an integral role in eukaryotic nuclear metabolism and cell cycle control, our studies are of direct relevance to human health, cancer, and the mission of the NIH. This proposal seeks to address the functional significance for components of the SUMO conjugation pathway through structural, biochemical and genetic studies that will establish the basis for 1) SUMO and ubiquitin activation, 2) SUMO conjugation by E2 and E3 enzymes, 3) regulation of SUMO pathway through characterization of SUMO-binding domains and through studies that will determine the importance of SUMO surfaces in response to environmental stress such as DNA damage, 4) address the structural biology associated with SUMO modified PCNA and its recognition by the anti- recombinogenic helicase Srs2. Because the enzymes, mechanisms and co-factors that constitute the SUMO conjugation pathway are conserved or conceptually analogous to those in other Ub/Ubl pathways, our studies will be broadly relevant and will impact research on protein conjugation by Ub and other Ubl modifiers. PUBLIC HEALTH RELEVANCE: Reversible post-translational modifications relay information within and across cells in signal transduction pathways that control the spatial and temporal distribution of protein substrates. Covalent modification of proteins by ubiquitin (Ub) and ubiquitin-like (Ubl) proteins such as SUMO (small ubiquitin-like modifier) and Nedd8 impact nearly all facets of cellular metabolism including cell cycle control, protein degradation, protein localization, nuclear transport, cytokinesis, chromosome segregation, and transcriptional regulation among many others. This proposal seeks to explore the mechanisms that underlie protein modification by SUMO through structural, biochemical and genetic studies that will address 1) Ub/Ubl activation by the E1 enzyme, 2) SUMO conjugation by E2 and E3 enzymes, 3) structural determinants required for recognition of SUMO by SUMO binding proteins, and 4) structural analysis of PCNA, its modification by SUMO, and its recognition by Srs2. The SUMO pathway regulates many pathways that are associated with human disease conditions including neurodegenerative disorders, cancer, and inflammation.
描述(由申请人提供):信号转导途径依赖于可逆的化学修饰,在细胞内和细胞间传递信息。泛素样蛋白SUMO(小泛素样修饰物)对蛋白质底物的共价修饰有助于调节核心细胞功能的途径,包括核转运、胞质分裂、染色体分离、G2-M细胞周期进展和转录调节等。泛素(Ub)和泛素样(Ubl)蛋白如SUMO的翻译后修饰需要E1激活酶、E2缀合酶和E3连接酶的顺序作用,而Ub/Ubl加工和解缀合由Ub/Ubl特异性蛋白酶催化。由于SUMO结合在真核细胞核代谢和细胞周期控制中起着不可或缺的作用,我们的研究与人类健康、癌症和NIH的使命直接相关。该提案旨在通过结构、生物化学和遗传学研究来解决SUMO缀合途径组分的功能意义,这些研究将为1)SUMO和泛素活化,2)E2和E3酶的SUMO缀合,3)通过表征SUMO-1来调节SUMO途径。结合结构域,并通过研究,将确定SUMO表面的重要性,在响应环境压力,如DNA损伤,4)解决与SUMO修饰的PCNA相关的结构生物学及其被抗重组解旋酶Srs 2识别。由于构成SUMO缀合途径的酶、机制和辅因子与其他Ub/Ubl途径中的酶、机制和辅因子是保守的或在概念上类似,因此我们的研究将具有广泛的相关性,并将影响Ub和其他Ubl修饰剂对蛋白质缀合的研究。 公共卫生关系:可逆的翻译后修饰在信号转导通路中在细胞内和细胞间传递信息,控制蛋白质底物的空间和时间分布。泛素(Ub)和泛素样(Ubl)蛋白如SUMO(小泛素样修饰物)和Nedd 8对蛋白质的共价修饰几乎影响细胞代谢的所有方面,包括细胞周期控制、蛋白质降解、蛋白质定位、核转运、胞质分裂、染色体分离和转录调控等。本提案旨在通过结构、生物化学和遗传学研究探索SUMO修饰蛋白质的机制,这些研究将解决1)E1酶激活Ub/Ubl,2)E2和E3酶的SUMO结合,3)SUMO结合蛋白识别SUMO所需的结构决定因素,以及4)PCNA的结构分析,SUMO修饰及其Srs 2识别。SUMO通路调节许多与人类疾病相关的通路,包括神经退行性疾病、癌症和炎症。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHRISTOPHER D. LIMA其他文献

CHRISTOPHER D. LIMA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHRISTOPHER D. LIMA', 18)}}的其他基金

Structural studies of RNA processing and ubiquitin-like protein modification
RNA加工和类泛素蛋白修饰的结构研究
  • 批准号:
    9294090
  • 财政年份:
    2016
  • 资助金额:
    $ 39.69万
  • 项目类别:
Structural studies of RNA processing and ubiquitin-like protein modification
RNA加工和类泛素蛋白修饰的结构研究
  • 批准号:
    10163612
  • 财政年份:
    2016
  • 资助金额:
    $ 39.69万
  • 项目类别:
Structural studies of RNA processing and ubiquitin-like protein modification
RNA加工和类泛素蛋白修饰的结构研究
  • 批准号:
    10395543
  • 财政年份:
    2016
  • 资助金额:
    $ 39.69万
  • 项目类别:
Structural studies of RNA processing and ubiquitin-like protein modification
RNA加工和类泛素蛋白修饰的结构研究
  • 批准号:
    10597604
  • 财政年份:
    2016
  • 资助金额:
    $ 39.69万
  • 项目类别:
POST-TRANSLATIONAL PROTEIN MODIFICATION AND RNA PROCESSING AND DECAY
翻译后蛋白质修饰以及 RNA 加工和衰变
  • 批准号:
    8361610
  • 财政年份:
    2011
  • 资助金额:
    $ 39.69万
  • 项目类别:
2011 Nucleic Acids Gordon Research Conference
2011年核酸戈登研究会议
  • 批准号:
    8127037
  • 财政年份:
    2011
  • 资助金额:
    $ 39.69万
  • 项目类别:
POST-TRANSLATIONAL PROTEIN MODIFICATION AND RNA PROCESSING AND DECAY
翻译后蛋白质修饰以及 RNA 加工和衰变
  • 批准号:
    8169220
  • 财政年份:
    2010
  • 资助金额:
    $ 39.69万
  • 项目类别:
STRUCTURAL STUDIES OF MRNA METABOLISM & SUMO PROTEIN MODIFICATION
mRNA 代谢的结构研究
  • 批准号:
    7955097
  • 财政年份:
    2009
  • 资助金额:
    $ 39.69万
  • 项目类别:
Structural and Functional Studies of Eukaryotic Exosomes
真核外泌体的结构和功能研究
  • 批准号:
    8257600
  • 财政年份:
    2008
  • 资助金额:
    $ 39.69万
  • 项目类别:
Structural and Functional Studies of Eukaryotic Exosomes
真核外泌体的结构和功能研究
  • 批准号:
    7372050
  • 财政年份:
    2008
  • 资助金额:
    $ 39.69万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 39.69万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.69万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 39.69万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.69万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 39.69万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.69万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 39.69万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 39.69万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 39.69万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.69万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了